aratinga.bio Alternatives & Competitors
12 companies similar to aratinga.bio — aratinga.bio develops immunotherapies to treat cancer, including CAR T-cell plat...
Companies similar to aratinga.bio
Immugenia Inc.
Developing the next generation CAR therapy using hemopoietic stem cells to treat cancer an...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Novelogics Biotechnology Inc.
Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...
Canada
Cytovia Therapeutics
We empower Natural Killer cells to fight cancer through stem cell engineering and multispe...
Aventura, United States
Rival Readout
Competing with aratinga.bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
PACT Pharma
PACT Pharma is a privately held biotechnology company developing personalized T cell thera...
South San Francisco, Unit...
Tessa Therapeutics Ltd
A clinical-stage biotech company developing autologous and allogeneic cell therapies for t...
Singapore, Singapore
Curocell
Fight against hopelessness
Daejeon, Korea South
Mustang Bio
A fortress biotech Company
Waltham, United States
Oncoinvent ASA
Innovations for better cancer care
Oslo, Norway
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
SpecificiT Pharma
Pioneering personalized cancer therapies with a novel approach using Minor Histocompatibil...
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
About aratinga.bio
aratinga.bio is a preclinical stage biotechnology startup founded in 2017 and based in France. The company is dedicated to pioneering innovative immunotherapies for cancer treatment, particularly focusing on advancing a distinct CAR T-cell platform capable of effectively targeting both hematological and solid tumors, i...
Immunotherapy, Cancer Treatment, CAR T-cell Therapy, Preclinical Stage, Oncology, Innovation, Hematological Cancers, Solid Tumors, Proprietary Platform, Novel Therapies
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around aratinga.bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at aratinga.bio on 11 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
